Compounds > 1,3-dipropyl-8-(4-sulfophenyl)xanthine
Page last updated: 2024-10-21

1,3-dipropyl-8-(4-sulfophenyl)xanthine and Arterial Occlusive Diseases

1,3-dipropyl-8-(4-sulfophenyl)xanthine has been researched along with Arterial Occlusive Diseases in 1 studies

1,3-dipropyl-8-(4-sulfophenyl)xanthine: adenosine receptor antagonist

Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Monteiro, EC1
Ribeiro, JA1

Other Studies

1 other study available for 1,3-dipropyl-8-(4-sulfophenyl)xanthine and Arterial Occlusive Diseases

ArticleYear
Inhibition by 1,3-dipropyl-8(p-sulfophenyl)xanthine of the respiratory stimulation induced by common carotid occlusion in rats.
    Life sciences, 1989, Volume: 45, Issue:10

    Topics: Adenosine; Animals; Arterial Occlusive Diseases; Carotid Artery Diseases; Hemodynamics; Rats; Rats,

1989